scholarly journals A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy

2016 ◽  
Vol 1 (1) ◽  
pp. 131-138 ◽  
Author(s):  
Michelle Sexton ◽  
Carrie Cuttler ◽  
John S. Finnell ◽  
Laurie K. Mischley
Keyword(s):  
Medical Cannabis ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Perceived Efficacy ◽  
Patterns Of Use

Cannabis and End-of-Life Care: A Snapshot of Hospice Planning and Experiences Among Illinois Medical Cannabis Patients With A Terminal Diagnosis

2021 ◽  
pp. 104990912110186
Author(s):  
James Alton Croker ◽  
Julie Bobitt ◽  
Sara Sanders ◽  
Kanika Arora ◽  
Keith Mueller ◽  
...  
Keyword(s):  
Palliative Care ◽  
End Of Life ◽  
Fast Track ◽  
Hospice Care ◽  
Cannabis Use ◽  
Care Plan ◽  
Medical Cannabis ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Eol Care

Introduction: Between 2013 and 2019, Illinois limited cannabis access to certified patients enrolled in the Illinois Medical Cannabis Program (IMCP). In 2016, the state instituted a fast-track pathway for terminal patients. The benefits of medicinal cannabis (MC) have clear implications for patients near end-of-life (EOL). However, little is known about how terminal patients engage medical cannabis relative to supportive care. Methods: Anonymous cross-sectional survey data were collected from 342 terminal patients who were already enrolled in ( n = 19) or planning to enroll ( n = 323) in hospice for EOL care. Logistic regression models compare patients in the sample on hospice planning vs. hospice enrollment, use of palliative care vs. hospice care, and use standard care vs non-hospice palliative care. Results: In our sample, cancer patients ( OR = 0.21 (0.11), p < .01), and those who used the fast-track application into the IMCP ( OR = 0.11 (0.06), p < .001) were less likely to be enrolled in hospice. Compared to patients in palliative care, hospice patients were less likely to report cancer as their qualifying condition ( OR = 0.16 (0.11), p < .01), or entered the IMCP via the fast-track ( OR = 0.23 (0.15), p < .05). Discussion: Given low hospice enrollment in a fairly large EOL sample, cannabis use may operate as an alternative to supportive forms of care like hospice and palliation. Clinicians should initiate conversations about cannabis use with their patients while also engaging EOL Care planning discussions as an essential part of the general care plan.

scholarly journals What is associated with increased side effects and lower perceived efficacy following switching to a generic medicine? A New Zealand cross-sectional patient survey

BMJ Open ◽  
2018 ◽  
Vol 8 (10) ◽  
pp. e023667 ◽  
Author(s):  
Kate MacKrill ◽  
Keith J Petrie
Keyword(s):  
New Zealand ◽  
Side Effects ◽  
Generic Version ◽  
Drug Efficacy ◽  
Patient Survey ◽  
Generic Medicine ◽  
Cross Sectional Survey ◽  
Online Questionnaire ◽  
Cross Sectional ◽  
Perceived Efficacy

ObjectiveFollowing a switch from either a generic or branded antidepressant (venlafaxine) to a new generic, we investigated the factors associated with a preference for branded medicines, side effects reported following switching and efficacy ratings of the new generic drug.DesignA cross-sectional survey of patients switched to a new generic.SettingPatients accessing venlafaxine information online from the New Zealand government pharmaceuticals funding website.Participants310 patients, comprising 205 originally on branded venlafaxine and 105 previously taking a generic version.Main outcome measuresAn online questionnaire assessing demographic factors, perceived sensitivity to medicines, trust in pharmaceutical agencies, sources of switch information, preference for branded medicine, new medicine perceptions, side effects and efficacy ratings.ResultsPreference for branded medicine was significantly stronger in older patients (OR=1.04, 95% CI 1.01 to 1.05), those taking branded venlafaxine (OR=2.02, 95% CI 1.13 to 3.64) and patients with a higher perceived sensitivity to medicine (OR=1.23, 95% CI 1.06 to 1.19). Different factors predicted side effects in those switching from the branded and those switching from the generic venlafaxine. Trust in pharmaceutical agencies and the number of side effects were significant predictors of efficacy ratings of the new generic in both patients switching from a branded and those switching from a generic version of venlafaxine.ConclusionsIn patients switching from a branded medicine and those already taking a generic, different demographic and psychological factors are associated with preference for branded medicine, side effect reporting and perceived efficacy of the new drug. When switching to new generic, there appears to be a close bidirectional relationship between the experience of side effects and perceived drug efficacy. Trust in pharmaceutical agencies impacts directly on perceived efficacy and increasing such trust could reduce the nocebo response following a generic switch.

Patterns and perceived efficacy of herbal medicine for weight loss and maintenance: A cross-sectional survey from Jordan

2020 ◽  
Vol 35 ◽  
pp. 101086
Author(s):  
Amal Akour ◽  
Violet Kasabri ◽  
Nailya Bulatova ◽  
Suha Al Muhaissen ◽  
Ruba Al Tarawneh ◽  
...  
Keyword(s):  
Weight Loss ◽  
Herbal Medicine ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Perceived Efficacy

scholarly journals The Impact of Legalization of Access to Recreational Cannabis on Canadian Medical Users with Cancer.

2020 ◽  
Author(s):  
Philippa Helen Hawley ◽  
Monica Gobbo ◽  
Narsis Afghari
Keyword(s):  
Cancer Patients ◽  
Cannabis Use ◽  
P Value ◽  
Medical Cannabis ◽  
Eligibility Criteria ◽  
Cross Sectional ◽  
Access System ◽  
Patterns Of Use ◽  
Barriers To Access ◽  
The Impact

Abstract Background Canada legalized cannabis use for medical purposes in 1999. Legalization of cannabis for recreational purposes in October 2018 offered the opportunity to assess the impact of recreational legalization on cancer patients’ patterns of use to identify learning points that could be helpful to other countries considering similar legislation.Method Two identical anonymous cross-sectional surveys were administered to cancer patients in British Columbia (2 months before and 3 months following legalization), with the same eligibility criteria. The prevalence of medical cannabis use, the distribution of symptoms leading to use, the most common types of cannabis products and sources, reasons for stopping using cannabis, and barriers to access were assessed.Results The overall response rate was 27%. Both cohorts were similar regarding age (median= 66yrs), gender (53% female), and education (approximately 85% of participants had an education level of high school graduation and higher). Respondents had multiple motives for taking cannabis, including to manage multiple symptoms, to treat cancer, and for recreational reasons. The majority of patients in both surveys did not use the legal medical access system. Comparison of the two cohorts showed that after legalization the prevalence of current cannabis use increased by 26% (23·1% to 29·1%, p-value 0·01), including an increased disclosure of recreational motive for use, from 32% to 40%. However, in the post-legalization cohort more Current Users reported problems getting cannabis (18%) than the pre-legalization cohort (8%), (p-value <0·01). The most common barrier cited was lack of available preferred products, including edibles, as these were only available from illegal dispensaries. Conclusions Results showed that legalization of cannabis for recreational purposes may have an impact on those who use medical cannabis. Impacts include an increase in prevalence of use; problems accessing preferred products legally; higher cost, and difficulties using a legal access system. The desired goal of regulation in reducing harms from use of illegal cannabis products are unlikely to be achieved if the legal process is less attractive to patients than use of illegal sources.

scholarly journals SELF-MEDICATION AMONG ADULT POPULATION IN SELANGOR, MALAYSIA

2017 ◽  
Vol 9 (5) ◽  
pp. 268
Author(s):  
Suhana Jawahir ◽  
Noorizan Abd Aziz
Keyword(s):  
Adult Population ◽  
Common Source ◽  
Cross Sectional Survey ◽  
Self Medication ◽  
Cross Sectional ◽  
Medication Practice ◽  
Patterns Of Use ◽  
Validated Questionnaire ◽  
Important Health ◽  
Search For Information

Objective: Self-medication is a common practice and an important health issue worldwide. The aim of this study was to determine the percentage of self-medication practice, patterns of use, self-medication attitudes, and to explore the occurrence of side effects resulting from self-medication practice among the adult population in Selangor, Malaysia.Methods: This cross-sectional survey used a validated questionnaire administered to adults 18 y and above residing in Selangor.Results: A total of 401 completed questionnaires were analyzed. The majorities of the participants were Malay (91.5%) and went to college or university (89.3%). One-third self-medicated in the past two weeks prior to the survey. Self-medication was significantly associated with age (p=0.009) and race (p=0.038). Among the respondents, 83.8% would search for information before practicing self-medication. Modern healthcare professionals (58.4%) and the internet (47.1%) were the most common source of information about drugs for self-medication. The main reason for self-medication was the illness perceived as minor (79.1%). Two-thirds of the respondents (66.6%) had a satisfactory attitude towards self-medication practices.Conclusion: The public needs to be better informed on responsible self-medication to ensure safe, effective, and rational use of medicines.

scholarly journals ASSESSING HEALTH-RELATED OUTCOMES OF MEDICAL CANNABIS USE AMONG OLDER PERSONS IN COLORADO AND ILLINOIS

2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S204-S204 ◽  
Author(s):  
J Alton Croker ◽  
Julie Bobitt ◽  
Kanika Arora ◽  
Brian Kaskie
Keyword(s):  
Older Persons ◽  
Sleep Disturbances ◽  
Cannabis Use ◽  
Medical Cannabis ◽  
Treatment Needs ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Specific Patient ◽  
Patient Reported ◽  
Health Related

Abstract The use of cannabis is increasing among older Americans. A growing body of evidence shows cannabis and cannabinoids effective for treating chronic pain, spasticity, nausea, and sleep disturbances. States seeking to respond to the treatment needs of specific patient populations have legalized the use of cannabis for medical purposes. Few instruments offer standard outcomes for understanding the use of medial cannabis from the patient perspective, particularly focusing on older persons. Using cross-sectional survey data from a sample of older persons in Colorado and Illinois, we validate two scales to consistently measure patient-reported health related outcomes of medical cannabis use. We confirmed the validity of two separate, reliable outcome scales: a three-factor scale for measuring global health outcomes and a single-factor scale for capturing adverse health events. The COPS questionnaire revealed strong construct validity and internal consistency, and a lack of meaningful factor variance.

Sign in / Sign up

Export Citation Format

Share Document